vs
美国鹰（AEO）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
美国鹰的季度营收约是Revvity的1.8倍（$1.4B vs $772.1M），Revvity净利率更高（12.7% vs 6.7%，领先6.0%），Revvity同比增速更快（5.9% vs 5.7%），Revvity自由现金流更多（$161.8M vs $-2.5M），过去两年Revvity的营收复合增速更高（9.0% vs 2.3%）
American Eagle Outfitters是美国知名服饰及配饰零售商，总部位于宾夕法尼亚州匹兹堡市南区工业园。品牌1977年由杰里·西尔弗曼与马克·西尔弗曼兄弟创立，最初为零售风险投资公司的子公司，旗下还运营西尔弗曼男装。1980年创始人向肖滕斯坦家族出售一半股权，1991年售罄剩余股份，目前旗下拥有Aerie、Unsubscribed等多个品牌。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
AEO vs RVTY — 直观对比
营收规模更大
AEO
是对方的1.8倍
$772.1M
营收增速更快
RVTY
高出0.1%
5.7%
净利率更高
RVTY
高出6.0%
6.7%
自由现金流更多
RVTY
多$164.3M
$-2.5M
两年增速更快
RVTY
近两年复合增速
2.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $772.1M |
| 净利润 | $91.3M | $98.4M |
| 毛利率 | 40.5% | — |
| 营业利润率 | 8.3% | 14.5% |
| 净利率 | 6.7% | 12.7% |
| 营收同比 | 5.7% | 5.9% |
| 净利润同比 | 14.2% | 3.9% |
| 每股收益（稀释后） | $0.53 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEORVTY
| Q4 25 | $1.4B | $772.1M | ||
| Q3 25 | $1.3B | $698.9M | ||
| Q2 25 | $1.1B | $720.3M | ||
| Q1 25 | — | $664.8M | ||
| Q4 24 | $1.3B | $729.4M | ||
| Q3 24 | $1.3B | $684.0M | ||
| Q2 24 | $1.1B | $691.7M | ||
| Q1 24 | $1.7B | $649.9M |
净利润AEORVTY
| Q4 25 | $91.3M | $98.4M | ||
| Q3 25 | $77.6M | $46.7M | ||
| Q2 25 | $-64.9M | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | $80.0M | $94.6M | ||
| Q3 24 | $77.3M | $94.4M | ||
| Q2 24 | $67.8M | $55.4M | ||
| Q1 24 | $6.3M | $26.0M |
毛利率AEORVTY
| Q4 25 | 40.5% | — | ||
| Q3 25 | 38.9% | 53.6% | ||
| Q2 25 | 29.6% | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | 40.9% | — | ||
| Q3 24 | 38.6% | 56.3% | ||
| Q2 24 | 40.6% | 55.7% | ||
| Q1 24 | 36.6% | 54.6% |
营业利润率AEORVTY
| Q4 25 | 8.3% | 14.5% | ||
| Q3 25 | 8.0% | 11.7% | ||
| Q2 25 | -7.8% | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | 8.2% | 16.3% | ||
| Q3 24 | 7.8% | 14.3% | ||
| Q2 24 | 6.8% | 12.4% | ||
| Q1 24 | 0.6% | 6.8% |
净利率AEORVTY
| Q4 25 | 6.7% | 12.7% | ||
| Q3 25 | 6.0% | 6.7% | ||
| Q2 25 | -6.0% | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | 6.2% | 13.0% | ||
| Q3 24 | 6.0% | 13.8% | ||
| Q2 24 | 5.9% | 8.0% | ||
| Q1 24 | 0.4% | 4.0% |
每股收益（稀释后）AEORVTY
| Q4 25 | $0.53 | $0.86 | ||
| Q3 25 | $0.45 | $0.40 | ||
| Q2 25 | $-0.36 | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | $0.41 | $0.77 | ||
| Q3 24 | $0.39 | $0.77 | ||
| Q2 24 | $0.34 | $0.45 | ||
| Q1 24 | $0.03 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.8M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.6B | $7.3B |
| 总资产 | $4.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEORVTY
| Q4 25 | $112.8M | $919.9M | ||
| Q3 25 | $126.8M | $931.4M | ||
| Q2 25 | $87.9M | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $160.2M | $1.2B | ||
| Q3 24 | $191.8M | $1.2B | ||
| Q2 24 | $300.5M | $2.0B | ||
| Q1 24 | $454.1M | $1.7B |
总债务AEORVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
股东权益AEORVTY
| Q4 25 | $1.6B | $7.3B | ||
| Q3 25 | $1.5B | $7.4B | ||
| Q2 25 | $1.5B | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.7B | $7.7B | ||
| Q3 24 | $1.7B | $7.9B | ||
| Q2 24 | $1.8B | $7.9B | ||
| Q1 24 | $1.7B | $7.8B |
总资产AEORVTY
| Q4 25 | $4.2B | $12.2B | ||
| Q3 25 | $4.1B | $12.1B | ||
| Q2 25 | $3.8B | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | $3.7B | $12.4B | ||
| Q3 24 | $3.5B | $12.8B | ||
| Q2 24 | $3.6B | $13.4B | ||
| Q1 24 | $3.6B | $13.4B |
负债/权益比AEORVTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $161.8M |
| 自由现金流率自由现金流/营收 | -0.2% | 21.0% |
| 资本支出强度资本支出/营收 | 5.1% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.74× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-169.8M | $509.4M |
8季度趋势，按日历期对齐
经营现金流AEORVTY
| Q4 25 | $67.1M | $182.0M | ||
| Q3 25 | $27.8M | $138.5M | ||
| Q2 25 | $-54.7M | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | $52.9M | $174.2M | ||
| Q3 24 | $78.3M | $147.9M | ||
| Q2 24 | $-38.1M | $158.6M | ||
| Q1 24 | $296.4M | $147.6M |
自由现金流AEORVTY
| Q4 25 | $-2.5M | $161.8M | ||
| Q3 25 | $-43.1M | $120.0M | ||
| Q2 25 | $-116.3M | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | $-7.8M | $149.8M | ||
| Q3 24 | $17.5M | $125.6M | ||
| Q2 24 | $-74.3M | $136.6M | ||
| Q1 24 | $256.8M | $129.7M |
自由现金流率AEORVTY
| Q4 25 | -0.2% | 21.0% | ||
| Q3 25 | -3.4% | 17.2% | ||
| Q2 25 | -10.7% | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | -0.6% | 20.5% | ||
| Q3 24 | 1.4% | 18.4% | ||
| Q2 24 | -6.5% | 19.7% | ||
| Q1 24 | 15.3% | 20.0% |
资本支出强度AEORVTY
| Q4 25 | 5.1% | 2.6% | ||
| Q3 25 | 5.5% | 2.6% | ||
| Q2 25 | 5.7% | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 4.7% | 3.4% | ||
| Q3 24 | 4.7% | 3.3% | ||
| Q2 24 | 3.2% | 3.2% | ||
| Q1 24 | 2.4% | 2.7% |
现金转化率AEORVTY
| Q4 25 | 0.74× | 1.85× | ||
| Q3 25 | 0.36× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 0.66× | 1.84× | ||
| Q3 24 | 1.01× | 1.57× | ||
| Q2 24 | -0.56× | 2.87× | ||
| Q1 24 | 46.93× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEO
| American Eagle Brand | $800.4M | 59% |
| Aerie Brand | $429.1M | 31% |
| Other | $133.2M | 10% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
